KP-10614

N/A

Report date: 2024/12/05 15:15:10

Base Information

Drug NameKP-10614
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpoprostenol agonistsIntegrin alpha-IIb/beta-3 antagonistsProstanoid receptor agonists
TargetsIntegrin alpha-IIb/beta-3Prostanoid receptor
Therapy Area/IndicationsThrombosisMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMitsubishi Chemical
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMitsubishi Chemical
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial Ischemia

Other Information

ATC CodeN/A
Related LinksN/A